Cytokinetics Inc. buy Cantor Fitzgerald
Start price
09.09.24
/
50%
€50.00
Target price
09.09.25
-
Performance (%)
-13.20%
End price
10.09.25
€43.40
Summary
This prediction ended on 10.09.25 with a price of €43.40. The price of Cytokinetics Inc. has decreased during the runtime of the prediction. Compared to the start price this resulted in a performance of -13.20%. Cantor_Fitzgerald has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Cytokinetics Inc. | -7.759% | -7.759% | 17.841% |
| iShares Core DAX® | -0,38 % | 1,09 % | 11,64 % |
| iShares Nasdaq 100 | -0,41 % | -1,97 % | 7,27 % |
| iShares Nikkei 225® | 1,84 % | 10,26 % | 31,38 % |
| iShares S&P 500 | -0,71 % | 0,44 % | 4,30 % |
Comments by Cantor_Fitzgerald for this prediction
In the thread Discuss Cytokinetics Inc.
Cytokinetics, Incorporated (NASDAQ: CYTK) had its "overweight" rating re-affirmed by analysts at Cantor Fitzgerald.
Ratings data for CYTK provided by MarketBeat
In the thread Trading Cytokinetics Inc.
Die von Cantor_Fitzgerald gewählte maximale Laufzeit wurde überschritten